Close

VIVUS (VVUS) Holds Gains After Earlier Announcing Favorable Formulary Positioning for Qsymia

December 15, 2014 11:14 AM EST Send to a Friend
VIVUS, Inc. (NASDAQ: VVUS) today announced that Qsymia is the sole anti-obesity agent listed on the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login